Standard vs Modified Antiplatelet Preparation for Preventing Thromboembolic Events in Patients With High On-Treatment Platelet Reactivity Undergoing Coil Embolization for an Unruptured Intracranial Aneurysm
Author(s) -
Gyojun Hwang,
Won Huh,
Jin Soo Lee,
Jay Bautista Villavicencio,
Reynaldo Benedict V. Villamor,
Seong Yeol Ahn,
Junhak Kim,
Jun Young Chang,
Soo Joo Park,
Nam-Mi Park,
Eun-A Jeong,
O-Ki Kwon
Publication year - 2015
Publication title -
jama neurology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.298
H-Index - 231
eISSN - 2168-6157
pISSN - 2168-6149
DOI - 10.1001/jamaneurol.2015.0654
Subject(s) - medicine , clopidogrel , cilostazol , aspirin , batroxobin , surgery , randomized controlled trial , aneurysm , regimen , anesthesia , fibrinogen
Thromboembolism is the most common complication in coiling for an unruptured aneurysm and is frequent in patients with high on-treatment platelet reactivity (HTPR) who are prescribed a standard antiplatelet preparation for its prevention.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom